Serum vitamin E and blood glutathione peroxidase values of horses with degenerative myeloencephalopathy.

The study focuses on examining levels of serum vitamin E and blood glutathione peroxidase in horses with degenerative myeloencephalopathy, a disease of the nervous system, and comparing these levels with healthy, control horses. However, the research found no significant differences in these values between the two groups, challenging previous claims of vitamin E deficiency being a cause of the disease.

Background and Aim of the Study

• This study was conducted to investigate the potential connection between serum vitamin E and blood glutathione peroxidase values and the incidence of degenerative myeloencephalopathy in horses. Degenerative myeloencephalopathy is a neurodegenerative disease that typically affects young horses and causes symptoms like loss of coordination, weakness, and difficulty walking.
• Prior to this research, it was hypothesized that vitamin E deficiency could be a significant cause of this disease. The researchers embarked on this study to either confirm or refute this hypothesis by comparing the serum vitamin E and blood glutathione peroxidase values between horses with the disease and those without.

Methodology

• The target population of the study consisted of 40 horses with a histologically confirmed diagnosis of degenerative myeloencephalopathy, and 49 control horses that represented the same age range and exhibited normal neurologic function.
• Blood samples were obtained from both groups of horses. From these samples, serum vitamin E and blood glutathione peroxidase values were determined for comparative analysis.

Results and Interpretation

• The results of the analysis showed no significant differences in the levels of serum vitamin E or blood glutathione peroxidase between horses with degenerative myeloencephalopathy and the control horses.
• Based on these results, the hypothesis of vitamin E deficiency being a cause of equine degenerative myeloencephalopathy was not supported. This suggests that other factors than vitamin E deficiency may be contributing to the manifestation of the disease in horses.

Conclusions

• This study’s findings challenge previously held beliefs about the causes of degenerative myeloencephalopathy in horses. Specifically, the results debunk the idea that vitamin E deficiency is a significant factor in the disease’s onset or progression.
• The lack of significant differences in serum vitamin E and blood glutathione peroxidase levels in horses with the disease and healthy horses highlights the need for further research to explore other possible causes of the condition.